The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities
Abstract
Extracellular nucleotides and nucleosides mediate diverse signaling effects in virtually all organs and tissues. Most models of purinergic signaling depend on functional interactions between distinct processes, including (i) the release of endogenous ATP and other nucleotides, (ii) triggering of signaling events via a series of nucleotide-selective ligand-gated P2X and metabotropic P2Y receptors as well as adenosine receptors and (iii) ectoenzymatic interconversion of purinergic agonists. The duration and magnitude of purinergic signaling is governed by a network of ectoenzymes, including the enzymes of the nucleoside triphosphate diphosphohydrolase (NTPDase) family, the nucleotide pyrophosphatase/phosphodiesterase (NPP) family, ecto-5'-nucleotidase/CD73, tissue-nonspecific alkaline phosphatase (TNAP), prostatic acid phosphatase (PAP) and other alkaline and acid phosphatases, adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP). Along with "classical" inactivating ectoenzymes, recent data provide evidence for the co-existence of a counteracting ATP-regenerating pathway comprising the enzymes of the adenylate kinase (AK) and nucleoside diphosphate kinase (NDPK/NME/NM23) families and ATP synthase. This review describes recent advances in this field, with special emphasis on purine-converting ectoenzymes as a complex and integrated network regulating purinergic signaling in such (patho)physiological states as immunomodulation, inflammation, tumorigenesis, arterial calcification and other diseases. The second part of this review provides a comprehensive overview and basic principles of major approaches employed for studying purinergic activities, including spectrophotometric Pi-liberating assays, high-performance liquid chromatographic (HPLC) and thin-layer chromatographic (TLC) analyses of purine substrates and metabolites, capillary electrophoresis, bioluminescent, fluorometric and electrochemical enzyme-coupled assays, histochemical staining, and further emphasizes their advantages, drawbacks and suitability for assaying a particular catalytic reaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–226 of 226
Measurement of purine release with microelectrode biosensors
Dale, N., & Frenguelli, B. G. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9273-4 · Cited by 47
A Novel Mechanism of γ/δ T-Lymphocyte and Endothelial Activation by Shear Stress
Fu, Y., Hou, Y., Fu, C., Gu, M., Li, C., Kong, W., Wang, X., Shyy, J. Y.-J., & Zhu, Y. (2010) · Circulation Research · doi:10.1161/circresaha.110.230151 · Cited by 47
Yegutkin, G. G., Helenius, M., Kaczmarek, E., Burns, N., Jalkanen, S., Stenmark, K. R., & Gerasimovskaya, E. V. (2011) · Angiogenesis · doi:10.1007/s10456-011-9234-0 · Cited by 46
Self-citationAlbright, R. A., Ornstein, D. L., Cao, W., Chang, W. C., Robert, D., Tehan, M., Hoyer, D., Liu, L., Stabach, P. R., Yang, G., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.505867 · Cited by 46
Learning about the functions of NME/NM23: lessons from knockout mice to silencing strategies
Boissan, M., & Lacombe, M. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0649-3 · Cited by 45
NPP4 is a procoagulant enzyme on the surface of vascular endothelium
Albright, R. A., Chang, W. C., Robert, D., Ornstein, D. L., Cao, W., Liu, L., Redick, M. E., Young, J. I., Cruz, E. M. D. L., & Braddock, D. T. (2012) · Blood · doi:10.1182/blood-2012-04-425215 · Cited by 44
Nucleotides in the Eye: Focus on Functional Aspects and Therapeutic Perspectives
Guzmán‐Aránguez, A., Santano, C., Martín‐Gil, A., Fonseca, B., & Pintor, J. J. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.202473 · Cited by 43
ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer
Pan, J., Sun, L.-C., Tao, Y., Zhou, Z., Du, X.-L., Peng, L., Feng, X., Wang, J., Li, Y.-P., Liu, L., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-211 · Cited by 41
Kirino, M., Parnes, J. A., Hansen, A., Kiyohara, S., & Finger, T. E. (2013) · Open Biology · doi:10.1098/rsob.130015 · Cited by 40
Quintero, I. B., Herrala, A. M., Araujo, C. L., Pulkka, A. E., Hautaniemi, S., Ovaska, K., Pryazhnikov, E., Kulesskiy, E., Ruuth, M. K., Soini, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073072 · Cited by 39
Purines as potential morphogens during embryonic development
Massé, K. L., & Dale, N. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9290-y · Cited by 38
Ecto-5′-Nucleotidase, CD73, Is an Endothelium-Derived Hyperpolarizing Factor Synthase
Ohta, M., Toyama, K., Gutterman, D. D., Campbell, W. B., Lemaître, V., Teraoka, R., & Miura, H. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300600 · Cited by 38
A role for nucleotides in support of breast cancer angiogenesis: heterologous receptor signalling
Yokdang, N., Tellez, J. D., Tian, H., Norvell, J., Barsky, S. H., Valencik, M. L., & Buxton, I. L. O. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.134 · Cited by 38
Origin, utilization, and recycling of nucleosides in the central nervous system
Ipata, P. L. (2011) · AJP Advances in Physiology Education · doi:10.1152/advan.00068.2011 · Cited by 38
Frittitta, L., Camastra, S., Baratta, R., Costanzo, B. V., D’Adamo, M., Graci, S., Spampinato, D., Maddux, B. A., Vigneri, R., Ferrannini, E., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3620 · Cited by 37
IMMUNODEFICIENCY CAUSED BY PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY
Cohen, A., Grunebaum, E., Arpaia, E., & Roifman, C. M. (2000) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(05)70139-9 · Cited by 36
Adenosine Signaling: Good or Bad in Erectile Function?
Wen, J., & Xia, Y. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.226803 · Cited by 36
Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis
Buxton, I. L. O., Yokdang, N., & Matz, R. M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.021 · Cited by 33
Ecto-nucleotidases distribution in human cyclic and postmenopausic endometrium
Aliagas, E., Vidal, A., Torrejón-Escribano, B., Taco, M. D. R., Ponce, J., de Aranda, I. G., Sévigny, J., Condom, E., & Martín-Satué, M. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9345-0 · Cited by 31
Loukovaara, S., Sahanne, S., Jalkanen, S., & Yegutkin, G. G. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12507 · Cited by 31
Self-citationMercier, N., Kiviniemi, T., Saraste, A., Miiluniemi, M., Silvola, J. M. U., Jalkanen, S., & Yegutkin, G. G. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.002 · Cited by 29
Self-citationToro-Montoya, A. I., Paiva, M., Ackerley, C. A., & Grunebaum, E. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.07.003 · Cited by 29
Development of a Novel Ectonucleotidase Assay Suitable for High-Throughput Screening
Sachsenmeier, K. F., Hay, C. M., Brand, E., Clarke, L., Rosenthal, K., Guillard, S., Rust, S. J., Minter, R., & Hollingsworth, R. E. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112443987 · Cited by 21
Lack of ecto-5′-nucleotidase (CD73) promotes arteriogenesis
Böring, Y. C., Flögel, U., Jacoby, C., Heil, M., Schaper, W. K. A., & Schrader, J. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs286 · Cited by 20
Yegutkin, G. G., Hytönen, J., Samburski, S. S., Yrjänäinen, H., Jalkanen, S., & Viljanen, M. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902760 · Cited by 19
Self-citationAraujo, C. L., Quintero, I. B., Kipar, A., Herrala, A. M., Pulkka, A. E., Saarinen, L., Hautaniemi, S., & Vihko, P. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00062.2014 · Cited by 16
Cited by
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927
Extracellular purines, purinergic receptors and tumor growth
Di Virgilio, F., & Adinolfi, E. (2017) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 559
The P2X7 receptor: A main player in inflammation
Adinolfi, E., Giuliani, A. L., De Marchi, E., Pegoraro, A., Orioli, E., & Di Virgilio, F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.021 · Cited by 385
“Once in the extracellular space ATP undergoes a rapid enzymatic degradation mediated by ectonucleotidases, which control not only the half-life of ATP as agonist, but also generate ligands for additional purinergic receptors such as ADP-activated P2Y1, P2Y12 or P2Y13, or the adenosine-selective A1, A2A, A2B and A3 rec…”
Adenosine Metabolism: Emerging Concepts for Cancer Therapy
Boison, D., & Yegutkin, G. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.007 · Cited by 336
Self-citationP2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129
“The actions of the Purines are efficiently controlled by an extracellular enzymatic chain collectively called ectonucleotidases [31,32].”
Background
Metadata
- Authors
- Yegutkin, G. G.
- Venue
- Critical Reviews in Biochemistry and Molecular Biology
- Publisher
- Informa UK Limited
- Published
- 2014-11
- Volume
- 49
- Issue
- 6
- Pages
- 473-497
- ISSN
- 0045-6411 (ISSN-L)
- 1040-9238
- 1549-7798
- OpenAlex
- W2026003140
- Cited by
- 299
- References
- 226
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.